The Daily Raise/August 3, 2026
Funding round
Inocras raises $31M Series B round
Inocras (United States) has raised $31M in a Series B round, announced on August 3, 2026. The company is Provides whole-genome sequencing and automated cancer analytics for clinical diagnosis. The round was led by NDS Corporation, with participation from Aimed Bio Inc., IMM Investment, Korea Investment & Securities, LoftyRock Investment, DT& Investment, Woori Investment & Securities, Shinhan Securities.
Inocras closed an oversubscribed $31 million Series B-3 financing to expand its U.S. sequencing, laboratory, and analytics infrastructure.
Track every raise, every day
This deal appeared in The Daily Raise, August 3, 2026. Get the next edition in your inbox.
Just raised too?
Turn your funding news into guaranteed media coverage while the momentum lasts.